🇺🇸 FDA
Pipeline program

RD14-01

BHCT-RD14-01-02

Phase 2 mab active

Quick answer

RD14-01 for Solid Tumor is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Solid Tumor
Phase
Phase 2
Modality
mab
Status
active

Clinical trials